Navigation Links
Corbett Accel Healthcare Group Mourns Passing of Founder Frank J. Corbett
Date:2/11/2010

CHICAGO, Feb. 11 /PRNewswire/ -- Corbett Accel Healthcare Group (CAHG) is saddened to announce the passing of Frank Corbett, founder of Frank J. Corbett, Inc. an established leader in the field of medical advertising.

"Frank was a pioneer in our industry, a legend, a leader for the ages. More importantly, he was a professional, a true gentleman," said CAHG's CEO, Scott D. Cotherman. "His passion and drive for our industry was evident in all that he accomplished throughout his academic and professional careers."

Corbett began his illustrious career in the healthcare market after earning his degree in pharmacy from Columbia University in 1938. Corbett's subsequent accomplishments in pharmaceuticals and marketing eventually led him to establish Frank J. Corbett, Inc. in 1962 with his wife Dolores as his creative director and partner.  With Frank's leadership playing a key role, the Corbett agency helped develop brands such as Keri Lotion and Fostex for Westwood, Synthroid for Flint, and Bronchometer for Breon.

Corbett is known industry-wide for not only his professionalism and creativity, but also for his kind demeanor and contagious energy.  His vision and foresight helped build his namesake agency into the competitive force it is today.  Corbett's successes were recognized with the industry's highest honor in 1998 when he was inducted into the Medical Advertising Hall of Fame after formally retiring the previous year.  The organization has established a tribute site to celebrate and preserve the legacy of its founder, and the following hyperlink will take you to the tribute site for Frank Corbett:  http://www.cahg.com/frankcorbetttribute/. This site commemorates the life and accomplishments of this legendary man and presents the opportunity to submit a personal tribute about Frank for consideration and posting to the site, as well as the opportunity to provide a donation to the Michael J. Fox Foundation, a not-for-profit organization dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda.  

CAHG is comprised of 6 Business Units and provides brand stewardship throughout the lifecycle of a brand from compound development to patent expiry and beyond—including clinical trial patient recruitment and management from Iris Global Clinical Trial Solutions™; market-conditioning, promotional medical education from Accel Health; full-service interactive support through relationship marketing and digital/interactive communications from Kinect; and technology-inspired studio solutions through LinQ.  Surge Worldwide Healthcare Communications and Corbett Worldwide Healthcare Communications offer global brand stewardship in the professional healthcare advertising, branding, and promotions disciplines.

CAHG is a wholly owned subsidiary of Omnicom Group Inc. (NYSE: OMC) (www.omnicomgroup.com). As a member of the Diversified Agency Services (DAS) division of Omnicom Group, it is part of a global network of brand-building resources with affiliates specializing in professional communications, direct-to-consumer advertising, medical education, digital media, customer relationship marketing, public relations, and a variety of specialty disciplines all around the world.

SOURCE Corbett Accel Healthcare Group

RELATED LINKS
http://www.omnicomgroup.com

'/>"/>

SOURCE Corbett Accel Healthcare Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Attorney General Corbett urges Congress to Strike Nebraska Provision from Health Care Legislation or Face Potential Legal Challenge
2. PCAR Recognizes Corbett, Metro Bank and Other Award Recipients
3. Pennsylvania Attorney General Corbett Announces a Multi-State, $7 Million Settlement With Airborne Health, Inc., Over Charges of Deceptive Advertising
4. Corbett Worldwide Scores Gold at the 2008 MM&M Awards
5. Vertos Medical, Inc. Appoints James M. Corbett Chief Executive Officer
6. Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation
7. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
8. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
9. Pennsylvania Attorney General Corbett, American Lung Association & Others Call for New MSA Funds to Be Used for Tobacco Prevention and Cessation
10. Attorney General Corbett Announces $36.7 Million Multi-State Settlement With CVS/Caremark in National Dosage-Switching Investigation
11. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... , ... Five consumer packaged goods (CPG) products were selected by the SupplySide ... Nopavera Plus was named to the short list in the Specialty Supplements category. ... presentations at SupplySide Central on Sept. 27 and 28 at Mandalay Bay Resort in ...
(Date:9/20/2017)... ... 2017 , ... “The Trials I Face to Receive God’s Grace”: a ... aspirations and goals to better one’s life through God. “The Trials I Face to ... all the wrong places, found a love for writing. Green feels that expressing his ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is ... of mind and move the readers one step closer to God. “Psalms of Humidity” ... that his mistakes that have been made within his life are the very same ...
(Date:9/19/2017)... ... September 19, 2017 , ... With a series of ... more than $15,000 in just a couple of weeks for those affected by ... world-class instructor seminars, organizers expect to double those initial funds with the “Submit ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Compliance and Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual ... Innovation to Action Award. , The Innovation to Action Award, a USAID ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/29/2017)... 2017 ivWatch, LLC, the leading provider of continuous monitoring ... has been awarded an Innovative Technology contract from Vizient, Inc., the ... ... in the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ...
Breaking Medicine Technology: